BackGlobus Medical Overview

Globus Medical Profit Margin

Latest profit margin for Globus Medical: 17.03% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

19.20%
29.47% YoY

As of Jun 2026

Annual Profit Margin (TTM)

17.03%
25.39% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Globus Medical (GMED) FAQ

Globus Medical (GMED) currently reports a profit margin of 17.03% as of June 2026. That compares with 13.58% in the prior-year period — up 25.4% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore Globus Medical's profit margin history and peer comparisons.

Globus Medical's profit margin increased from 13.58% to 17.03% — a 25.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Globus Medical's profit margin of 17.03% is higher than the Healthcare sector average of 13.89%. That is roughly 22.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Globus Medical's current 17.03% should be judged against Healthcare norms (sector average: 13.89%) and against GMED's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 17.03%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Globus Medical, and consider following GMED for alerts when major investors trade the stock.